Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
The hepatitis B epidemic in China should receive more attention
The Lancet ( IF 168.9 ) Pub Date : 2018-04-21 , DOI: 10.1016/s0140-6736(18)30499-9 Shanquan Chen , Jun Li , Dan Wang , Hong Fung , Lai-yi Wong , Lu Zhao
The Lancet ( IF 168.9 ) Pub Date : 2018-04-21 , DOI: 10.1016/s0140-6736(18)30499-9 Shanquan Chen , Jun Li , Dan Wang , Hong Fung , Lai-yi Wong , Lu Zhao
China's childhood hepatitis B virus (HBV) vaccination programme is a great public health success, resulting in a prevalence of HBsAg of only 1% in children under 5 years. However, the burden of HBV infection in China is still the highest in the world, with one third of the world's 240 million people with chronic HBV living in China.1 Nevertheless, most people with HBV infection in China are unaware that they carry the disease, making HBV infection a truly silent epidemic.2
更新日期：2018-04-20
京公网安备 11010802027423号